BusinessSelecta Biosciences Presents Preclinical Data Regarding SVP-Enabled Peanut Allergy Therapeutic Vaccine and Celiac Disease TreatmentBy Nasdaq OMXFeb 6, 2017, 1:00 PM UTC
BusinessSelecta Biosciences to Participate in Two Investor Conferences in FebruaryBy Nasdaq OMXJan 31, 2017, 1:00 PM UTC
BusinessFluidigm Announces New Integrated Fluidic Circuits for Single-Cell Genomics on the C1 SystemBy Nasdaq OMXApr 12, 2016, 12:44 PM UTC
